Literature DB >> 8514398

Variant cysteine-rich surface proteins of Giardia isolates from human and animal sources.

T Bruderer1, P Papanastasiou, R Castro, P Köhler.   

Abstract

Cloned Giardia isolates obtained from a sheep, a calf, and a human possessed a major membrane protein that showed marked intraspecific variations in size as demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis following surface biotinylation and radioiodination. Metabolic labeling with [35S] cysteine and electrophoretic analysis also revealed for each cloned isolate a predominant protein that corresponded in size to the major surface protein demonstrated by surface labeling techniques. Immunoprecipitation studies with a polyclonal antiserum specifically directed against the 90-kDa major cysteine-rich protein purified from a subclone of the sheep isolate (O2-4A1) showed that the cysteine-rich protein and the major surface protein are identical. The surface location of the antigen was further corroborated by the reaction of fluorescence-labeled antibodies raised against the 90-kDa O2-4A1 cysteine-rich protein with the entire surface of live trophozoites of the homologous clone. The ability of the cloned Giardia isolates to undergo variations of their cysteine-rich surface protein (CRISP) was demonstrated by the spontaneous appearance of new CRISPs in clonally derived populations during prolonged in vitro culturing and in cultures of the O2-4A1 clone that had survived treatment with the cytotoxic anti-90-kDa CRISP antiserum specific for the surface antigen of this clone. The surviving progeny were devoid of the original CRISP, as judged by resistance to the immune serum. Subsequent cysteine metabolic labeling of the recloned surviving trophozoites demonstrated a large number of new variants, each expressing a single CRISP that varied significantly in molecular weight from those in the different cloned lines. These studies suggest that the presence of CRISPs and their variations are not restricted to Giardia isolates obtained from humans but are universal phenomena among the Giardia duodenalis types of organisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514398      PMCID: PMC280942          DOI: 10.1128/iai.61.7.2937-2944.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Frequency of variant antigens in Giardia lamblia.

Authors:  T E Nash; S M Banks; D W Alling; J W Merritt; J T Conrad
Journal:  Exp Parasitol       Date:  1990-11       Impact factor: 2.011

2.  Characterization of a Giardia lamblia variant-specific surface protein (VSP) gene from isolate GS/M and estimation of the VSP gene repertoire size.

Authors:  T E Nash; M R Mowatt
Journal:  Mol Biochem Parasitol       Date:  1992-04       Impact factor: 1.759

3.  Cysteine-rich variant surface proteins of Giardia lamblia.

Authors:  A Aggarwal; J W Merritt; T E Nash
Journal:  Mol Biochem Parasitol       Date:  1989-01-01       Impact factor: 1.759

4.  Antigenic variation in Giardia lamblia.

Authors:  T E Nash; A Aggarwal; R D Adam; J T Conrad; J W Merritt
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Electrophoretic characterization of Giardia isolated from humans, cattle, sheep, and a dog in Switzerland.

Authors:  A M Strandén; J Eckert; P Köhler
Journal:  J Parasitol       Date:  1990-10       Impact factor: 1.276

7.  Giardia intestinalis: electrophoretic evidence for a species complex.

Authors:  R H Andrews; M Adams; P F Boreham; G Mayrhofer; B P Meloni
Journal:  Int J Parasitol       Date:  1989-04       Impact factor: 3.981

8.  The epidemiology of Giardiasis.

Authors:  E A Meyer
Journal:  Parasitol Today       Date:  1985-10

9.  A surface antigen of Giardia lamblia with a glycosylphosphatidylinositol anchor.

Authors:  S Das; A Traynor-Kaplan; D S Reiner; T C Meng; F D Gillin
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

10.  Biochemical and immunological characterization of major surface antigens of Sarcocystis muris and S. suicanis cyst merozoites.

Authors:  I Sommer; H Mehlhorn; W Rüger
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

View more
  7 in total

1.  The secretory apparatus of an ancient eukaryote: protein sorting to separate export pathways occurs before formation of transient Golgi-like compartments.

Authors:  Matthias Marti; Yajie Li; Elisabeth M Schraner; Peter Wild; Peter Köhler; Adrian B Hehl
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

Review 2.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Separation of a cysteine-rich surface antigen-expressing variant from a cloned Giardia isolate by fluorescence-activated cell sorting.

Authors:  T Bruderer; E Niederer; P Köhler
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

4.  Stage-specific expression and targeting of cyst wall protein-green fluorescent protein chimeras in Giardia.

Authors:  A B Hehl; M Marti; P Köhler
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

5.  The variant-specific surface protein of Giardia, VSP4A1, is a glycosylated and palmitoylated protein.

Authors:  P Papanastasiou; M J McConville; J Ralton; P Köhler
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

6.  Comparison of genetic groups determined by molecular and immunological analyses of Giardia isolated from animals and humans in Switzerland and Australia.

Authors:  P L Ey; T Bruderer; C Wehrli; P Köhler
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

7.  Serum Cohn fraction IV-1 supports the growth of Giardia lamblia in vitro.

Authors:  H D Lujan; L G Byrd; M R Mowatt; T E Nash
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.